Term: | ledipasvir |
|
Accession: | CHEBI:85089
|
browse the term
|
Definition: | A benzimidazole derivative that is used in combination with sofosbuvir (under the trade name Harvoni) for the treatment of chronic hepatitis C genotype 1 infection. |
Synonyms: | exact_synonym: | methyl [(2S)-1-{(6S)-6-[4-(9,9-difluoro-7-{2-[(1R,3S,4S)-2-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-5-yl}-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl}-3-methyl-1-oxobutan-2-yl]carbamate |
| related_synonym: | Formula=C49H54F2N8O6; GS-5885; GS5885; InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1; InChIKey=VRTWBAAJJOHBQU-KMWAZVGDSA-N; SMILES=COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1c1nc(c[nH]1)-c1ccc2-c3ccc(cc3C(F)(F)c2c1)-c1ccc2[nH]c(nc2c1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C; WHO 9796 |
| xref: | CAS:1256388-51-8; Drug_Central:4899; KEGG:D10442 |
| xref_mesh: | MESH:C586541 |
| xref: | PMID:25553890; PMID:25591505; PMID:25619871; PMID:25627448; PMID:25674516; PMID:25674658; PMID:25676581; PMID:25706232; PMID:25706754; Reaxys:23926149; Wikipedia:Ledipasvir |
|
|